Last reviewed · How we verify
NCT05367466
Risk Factors of Neonatal Thrombosis
trial in Thrombosis in 11 participants. Completed in 10 April 2022.
30 December 2019
Quick facts
| Lead sponsor | Kırıkkale University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 1 January 2014 |
| Primary completion | 30 December 2019 |
| Estimated completion | 10 April 2022 |
Conditions studied
- Thrombosis — all drugs for Thrombosis →
Sponsor
Kırıkkale University
Who can join
1 Day and older, any sex, with Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The incidence of symptomatic thrombosis is between 2.4 and 6.8 per 1000 neonatal intensive care unit admission while it is 5.1 per 100 000 live births. Compared to adults, the anticoagulant and fibrinolytic system of newborns is significantly different. In this study, the aim is to evaluate infants with neonatal thrombosis in our unit to characterize acquired and genetic risk factors, the laboratory work-up parameters and the diagnosis approach.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of Patients with Neonatal Thrombosis.
Guzoglu N, Albayrak M, Aliefendioglu D. · · 2023 · cited 1× · PMID 36859514 · DOI 10.1007/s12098-023-04497-w
Verify or expand the search:
- PubMed search for NCT05367466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thrombosis
Currently open trials in the same condition.
- NCT07137429 — Platelet Volunteers, Longitudinal and Multi-omic Study · recruiting
- NCT06676904 — Neonatal Platelet Transfusion Threshold Trial · NA · recruiting
- NCT06993740 — Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient · NA · recruiting
- NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting
- NCT06370273 — Thromboprophylaxis in Lower Limb Immobilisation · Phase 3 · recruiting
Other Kırıkkale University trials
Trials by the same sponsor.
- NCT07323420 — Effects of Different Inspiratory:Expiratory Ratios on Respiratory and Recovery Outcomes During Dental Procedures Under G · recruiting
- NCT07504861 — Biomarkers in Apical Periodontitis · not yet recruiting
- NCT07451860 — Chronic Total Occlusion and Triglyceride-Glucose Index · not yet recruiting
- NCT06921369 — The Effect of Compassionate Care Education on Nurses · NA · not yet recruiting
- NCT07338253 — The Effect of the Flipped Learning Model on Spiritual Care Perception and Competence in Nursing Students · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05367466 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kırıkkale University
- Last refreshed: 10 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05367466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing